| Literature DB >> 28125802 |
Joyce A Nettleton1, Ingeborg A Brouwer, Johanna M Geleijnse, Gerard Hornstra.
Abstract
At a workshop to update the science linking saturated fatty acid (SAFA) consumption with the risk of coronary heart disease (CHD) and ischemic stroke, invited participants presented data on the consumption and bioavailability of SAFA and their functions in the body and food technology. Epidemiological methods and outcomes were related to the association between SAFA consumption and disease events and mortality. Participants reviewed the effects of SAFA on CHD, causal risk factors, and surrogate risk markers. Higher intakes of SAFA were not associated with higher risks of CHD or stroke apparently, but studies did not take macronutrient replacement into account. Replacing SAFA by cis-polyunsaturated fatty acids was associated with significant CHD risk reduction, which was confirmed by randomized controlled trials. SAFA reduction had little direct effect on stroke risk. Cohort studies suggest that the food matrix and source of SAFA have important health effects.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28125802 PMCID: PMC5475232 DOI: 10.1159/000455681
Source DB: PubMed Journal: Ann Nutr Metab ISSN: 0250-6807 Impact factor: 3.374